The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.

According to the announcement, the possible contamination was discovered through routine testing conducted by an independent laboratory.

Martin Makary, commissioner of the Food and Drug Administration, on the push against ultra processed foods and added sugar, and what that could mean for school lunches and food labels, and says the administration's hierarchy of vaccines is meant to encourage childhood vaccine uptake.

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation and behavior from their labels following an investigation, the agency stated in a Jan.

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread clearance.

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss drugs. The U.S.

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System received several reports of suicidal ideation from users in 2023, though this wasn't a safety signal seen in any clinical trials or observational studies.

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

The FDA has been called out for its refusal to ban formaldehyde in hair straightening products, jeopardizing the health of Black women.